The Effect of Tegoprazan on Serum Gastrin Levels and the Development of Hypergastrinemia in the Maintenance Treatment for Gastroesophageal Reflux Disease: Comparison to Lansoprazole
Tegoprazan has a smaller impact on increasing serum gastrin levels and the development of hypergastrinemia than lansoprazole, suggesting that tegoprazan may reduce safety concerns related to hypergastrinemia, particularly at half doses.
Authors
- Da Hyun Jung (ORCID: https://orcid.org/0000-0001-6668-3113)
- Kwang Jae Lee (ORCID: https://orcid.org/0000-0001-7148-3765)
- O. Y. Lee
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Hanyang University (KR)
- Ajou University (KR)
Publication Details
- Journal
- Journal of Neurogastroenterology and Motility
- Published
- 2025-10-13
- DOI
- https://doi.org/10.5056/jnm25104
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00